These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1790419)

  • 1. Apparent beneficial effects of tamoxifen on bone mineral content in patients with breast cancer: preliminary study.
    Ryan WG; Wolter J; Bagdade JD
    Osteoporos Int; 1991 Oct; 2(1):39-41. PubMed ID: 1790419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tamoxifen on bone mineral density and metabolism in postmenopausal women with early-stage breast cancer.
    Zidan J; Keidar Z; Basher W; Israel O
    Med Oncol; 2004; 21(2):117-21. PubMed ID: 15299183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term adjuvant tamoxifen in early breast cancer: effect on bone mineral density in postmenopausal women.
    Fornander T; Rutqvist LE; Sjöberg HE; Blomqvist L; Mattsson A; Glas U
    J Clin Oncol; 1990 Jun; 8(6):1019-24. PubMed ID: 2189951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized study.
    Kristensen B; Ejlertsen B; Dalgaard P; Larsen L; Holmegaard SN; Transbøl I; Mouridsen HT
    J Clin Oncol; 1994 May; 12(5):992-7. PubMed ID: 8164053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of tamoxifen or exemestane on bone mineral density during the first 2 years of adjuvant treatment of postmenopausal women with early breast cancer.
    Jones S; Stokoe C; Sborov M; Braun M; Ethirajan S; Kutteh L; Pippen J; Patel M; Paul D; Blum JL; Holmes FA; Myron MC; Cantrell J; Hartung NL; Look RM; Di Salle E; Davis JC; Ilegbodu D; Asmar L
    Clin Breast Cancer; 2008 Dec; 8(6):527-32. PubMed ID: 19073509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that tamoxifen preserves bone density in late postmenopausal women with breast cancer.
    Resch A; Biber E; Seifert M; Resch H
    Acta Oncol; 1998; 37(7-8):661-4. PubMed ID: 10050983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer.
    Love RR; Mazess RB; Barden HS; Epstein S; Newcomb PA; Jordan VC; Carbone PP; DeMets DL
    N Engl J Med; 1992 Mar; 326(13):852-6. PubMed ID: 1542321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of adjuvant tamoxifen treatment on bone mineral density and bone turnover markers in postmenopausal breast cancer patients in Japan.
    Yoneda K; Tanji Y; Ikeda N; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
    Cancer Lett; 2002 Dec; 186(2):223-30. PubMed ID: 12213292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen protects against steroid-induced bone loss.
    Fentiman IS; Saad Z; Caleffi M; Chaudary MA; Fogelman I
    Eur J Cancer; 1992; 28(2-3):684-5. PubMed ID: 1591093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elemental composition of bone minerals in women with breast cancer treated with adjuvant tamoxifen.
    Kalef-Ezra JA; Pavlidis N; Klouvas G; Karantanas A; Hatzikonstantinou I; Glaros D
    Breast Cancer Res Treat; 1996; 37(2):161-8. PubMed ID: 8750583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone health in postmenopausal women with early breast cancer: how protective is tamoxifen?
    Ding H; Field TS
    Cancer Treat Rev; 2007 Oct; 33(6):506-13. PubMed ID: 17573199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status.
    Vehmanen L; Elomaa I; Blomqvist C; Saarto T
    J Clin Oncol; 2006 Feb; 24(4):675-80. PubMed ID: 16446340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial.
    Wagner-Johnston ND; Sloan JA; Liu H; Kearns AE; Hines SL; Puttabasavaiah S; Dakhil SR; Lafky JM; Perez EA; Loprinzi CL
    Cancer; 2015 Aug; 121(15):2537-43. PubMed ID: 25930719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of effects of tamoxifen and toremifene on bone biochemistry and bone mineral density in postmenopausal breast cancer patients.
    Marttunen MB; Hietanen P; Tiitinen A; Ylikorkala O
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1158-62. PubMed ID: 9543133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in bone turnover and in bone mass in women with breast cancer switched from tamoxifen to exemestane.
    Gonnelli S; Cadirni A; Caffarelli C; Petrioli R; Montagnani A; Franci MB; Lucani B; Francini G; Nuti R
    Bone; 2007 Jan; 40(1):205-10. PubMed ID: 16904960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two years.
    Love RR; Mazess RB; Tormey DC; Barden HS; Newcomb PA; Jordan VC
    Breast Cancer Res Treat; 1988 Dec; 12(3):297-302. PubMed ID: 3228591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of one-year adjuvant treatment with tamoxifen on bone mineral density in postmenopausal breast cancer women.
    Barni S; Lissoni P; Tancini G; Ardizzoia A; Cazzaniga M
    Tumori; 1996; 82(1):65-7. PubMed ID: 8623509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study.
    Coleman RE; Banks LM; Girgis SI; Kilburn LS; Vrdoljak E; Fox J; Cawthorn SJ; Patel A; Snowdon CF; Hall E; Bliss JM; Coombes RC;
    Lancet Oncol; 2007 Feb; 8(2):119-27. PubMed ID: 17267326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of exemestane, anastrozole and tamoxifen on bone mineral density and bone turnover markers in postmenopausal early breast cancer patients: results of N-SAS BC 04, the TEAM Japan substudy.
    Aihara T; Suemasu K; Takei H; Hozumi Y; Takehara M; Saito T; Ohsumi S; Masuda N; Ohashi Y
    Oncology; 2010; 79(5-6):376-81. PubMed ID: 21430407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Exemestane and Tamoxifen treatment on bone texture analysis assessed by TBS in comparison with bone mineral density assessed by DXA in women with breast cancer.
    Kalder M; Hans D; Kyvernitakis I; Lamy O; Bauer M; Hadji P
    J Clin Densitom; 2014; 17(1):66-71. PubMed ID: 23562130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.